journal
https://read.qxmd.com/read/38996533/the-deep-pockets-of-health-harming-industries
#1
JOURNAL ARTICLE
Talha Burki
No abstract text is available yet for this article.
July 9, 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38991584/efficacy-and-safety-of-sglt2-inhibitors-with-and-without-glucagon-like-peptide-1-receptor-agonists-a-smart-c-collaborative-meta-analysis-of-randomised-controlled-trials
#2
JOURNAL ARTICLE
Ellen M Apperloo, Brendon L Neuen, Robert A Fletcher, Niels Jongs, Stefan D Anker, Deepak L Bhatt, Javed Butler, David Z I Cherney, William G Herrington, Silvio E Inzucchi, Meg J Jardine, Chih-Chin Liu, Kenneth W Mahaffey, Darren K McGuire, John J V McMurray, Bruce Neal, Milton Packer, Vlado Perkovic, Marc S Sabatine, Scott D Solomon, Natalie Staplin, Michael Szarek, Muthiah Vaduganathan, Christoph Wanner, David C Wheeler, Stephen D Wiviott, Faiez Zannad, Hiddo J L Heerspink
BACKGROUND: SGLT2 inhibitors and GLP-1 receptor agonists both improve cardiovascular and kidney outcomes in patients with type 2 diabetes. We sought to evaluate whether the benefits of SGLT2 inhibitors are consistent in patients receiving and not receiving GLP-1 receptor agonists. METHODS: We conducted a collaborative meta-analysis of trials included in the SGLT2 Inhibitor Meta-Analysis Cardio-Renal Trialists' Consortium, restricted to participants with diabetes...
July 8, 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38991583/sglt2-inhibitors-and-glp-1-receptor-agonists-the-definitive-combination
#3
JOURNAL ARTICLE
Carlos Escobar Cervantes
No abstract text is available yet for this article.
July 8, 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38968941/impact-of-higher-bmi-on-cardiometabolic-risk-does-height-matter
#4
LETTER
Norbert Stefan, Catarina Schiborn, Jürgen Machann, Andreas L Birkenfeld, Matthias B Schulze
No abstract text is available yet for this article.
July 2, 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38964354/semaglutide-in-people-with-hiv-associated-lipohypertrophy
#5
JOURNAL ARTICLE
Y Joseph Hwang, Todd T Brown, Jacqueline Capeau
No abstract text is available yet for this article.
July 1, 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38964353/once-weekly-semaglutide-in-people-with-hiv-associated-lipohypertrophy-a-randomised-double-blind-placebo-controlled-phase-2b-single-centre-clinical-trial
#6
JOURNAL ARTICLE
Allison Ross Eckard, Qian Wu, Abdus Sattar, Kianoush Ansari-Gilani, Danielle Labbato, Theresa Foster, Aaron A Fletcher, Ruth O Adekunle, Grace A McComsey
BACKGROUND: HIV-associated lipohypertrophy, which is characterised by an abnormal accumulation of abdominal visceral adipose tissue, remains problematic in people with HIV. Effective interventions are lacking, despite HIV-associated lipohypertrophy carrying a substantial risk of cardiometabolic comorbidity. The primary aim of this trial was to investigate effects of the GLP-1 receptor agonist, semaglutide, on adipose tissue in HIV-associated lipohypertrophy. METHODS: This randomised, double-blind, placebo-controlled phase 2b clinical trial was conducted at a single US site...
July 1, 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38942044/the-potential-role-for-artificial-intelligence-in-fracture-risk-prediction
#7
REVIEW
Namki Hong, Danielle E Whittier, Claus-C Glüer, William D Leslie
Osteoporotic fractures are a major health challenge in older adults. Despite the availability of safe and effective therapies for osteoporosis, these therapies are underused in individuals at high risk for fracture, calling for better case-finding and fracture risk assessment strategies. Artificial intelligence (AI) and machine learning (ML) hold promise for enhancing identification of individuals at high risk for fracture by distilling useful features from high-dimensional data derived from medical records, imaging, and wearable devices...
June 25, 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38936372/value-of-early-pregnancy-hba-1c-to-predict-gestational-diabetes
#8
JOURNAL ARTICLE
Yashdeep Gupta, David Simmons
No abstract text is available yet for this article.
June 24, 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38936371/early-pregnancy-hba-1c-as-the-first-screening-test-for-gestational-diabetes-results-from-three-prospective-cohorts
#9
JOURNAL ARTICLE
Ponnusamy Saravanan, Mohan Deepa, Zain Ahmed, Uma Ram, Tarakeswari Surapaneni, Sailaja Devi Kallur, Papa Desari, Seshadri Suresh, Ranjit Mohan Anjana, Wesley Hannah, Chockalingam Shivashri, Saite Hemavathy, Nithya Sukumar, Wycliffe K Kosgei, Astrid Christoffersen-Deb, Vincent Kibet, John N Hector, Gertrude Anusu, Nigel Stallard, Yonas Ghebremichael-Weldeselassie, Norman Waugh, Sonak D Pastakia, Viswanathan Mohan
BACKGROUND: More than 90% of gestational diabetes cases are estimated to occur in low-income and middle-income countries (LMICs). Most current guidelines recommend an oral glucose tolerance test (OGTT) at 24-28 weeks of gestation. The OGTT is burdensome, especially in LMICs, resulting in a high proportion of women not being screened. We aimed to develop a simple and effective screening strategy for gestational diabetes. METHODS: STRiDE, a prospective cohort study, was set up in seven centres in south India and seven centres in western Kenya, and included pregnant women aged 18-50 years of age and at less than 16 weeks of gestation (<20 weeks in Kenya), confirmed by dating ultrasound...
June 24, 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38901446/call-for-effective-therapies-for-preventing-dementia-in-people-with-type-2-diabetes
#10
JOURNAL ARTICLE
Thomas T van Sloten, José A Luchsinger, Lenore J Launer, Mark Strachan, Tali Cukierman-Yaffe, Hertzel C Gerstein, Naveed Sattar, Geert Jan Biessels
No abstract text is available yet for this article.
June 17, 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38852596/alarming-rise-in-young-onset-type-2-diabetes
#11
EDITORIAL
The Lancet Diabetes Endocrinology
No abstract text is available yet for this article.
June 5, 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38843850/association-between-bmi-and-covid-19-on-hospital-budgets
#12
JOURNAL ARTICLE
Maya Nitecki, Arnon Afek, Gilad Twig
No abstract text is available yet for this article.
May 31, 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38843849/associations-between-bmi-and-hospital-resource-use-in-patients-hospitalised-for-covid-19-in-england-a-community-based-cohort-study
#13
JOURNAL ARTICLE
James Altunkaya, Carmen Piernas, Koen B Pouwels, Susan A Jebb, Philip Clarke, Nerys M Astbury, Jose Leal
BACKGROUND: Excess weight is a major risk factor for severe disease after infection with SARS-CoV-2. However, the effect of BMI on COVID-19 hospital resource use has not been fully quantified. This study aimed to identify the association between BMI and hospital resource use for COVID-19 admissions with the intention of informing future national hospital resource allocation. METHODS: In this community-based cohort study, we analysed patient-level data from 57 415 patients admitted to hospital in England with COVID-19 between April 1, 2020, and Dec 31, 2021...
May 31, 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38824930/lack-of-access-to-insulin-undermining-the-rights-of-the-child
#14
LETTER
Olivia Heller, Olivier Duperrex, Philip D Jaffé, Jeffrey Goldhagen, Carol A Abidha, Ann Skelton, Mikiko Otani, Yvon Heller, Jean-Dominique Vassalli, David Beran
No abstract text is available yet for this article.
May 30, 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38824929/causes-prevention-and-management-of-diabetes-related-foot-ulcers
#15
REVIEW
William Jeffcoate, Edward J Boyko, Fran Game, Prue Cowled, Eric Senneville, Robert Fitridge
In this Review, we aim to complement the 2023 update of the guidelines of the International Working Group on the Diabetic Foot. We highlight the complexity of the pathological processes that underlie diabetes-related foot ulceration (DFU) and draw attention to the potential implications for clinical management and outcome. Variation observed in the incidence and outcome of DFUs in different communities might result from differences in study populations and the accessibility of care. Comparing differences in incidence, management, and outcome of DFUs in different communities is an essential component of the quality of disease care...
May 30, 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38824928/diabetes-distress-the-psychological-burden-of-living-with-diabetes
#16
JOURNAL ARTICLE
Lydia Poole, Ruth A Hackett
No abstract text is available yet for this article.
May 30, 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38815594/advancing-diabetes-surveillance-ecosystems-a-case-study-of-india
#17
REVIEW
Jithin Sam Varghese, Emily N Peterson, Mohammed K Ali, Nikhil Tandon
Professional society and expert guidelines recommend the achievement of glycaemic, blood pressure, and cholesterol targets to prevent the microvascular and macrovascular complications of diabetes. The WHO Diabetes Compact recommends that countries meet and monitor these targets for diabetes management. Surveillance-ie, continuous, systematic measurement, analysis, and interpretation of data-is a crucial component of public health. In this Personal View, we use the case of India as an illustration of the challenges and future directions needed for a diabetes surveillance system that documents national progress and persistent gaps...
May 27, 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38797187/prediction-of-progression-to-type-1-diabetes-with-dynamic-biomarkers-and-risk-scores
#18
REVIEW
Mugdha V Joglekar, Simranjeet Kaur, Flemming Pociot, Anandwardhan A Hardikar
Identifying biomarkers of functional β-cell loss is an important step in the risk stratification of type 1 diabetes. Genetic risk scores (GRS), generated by profiling an array of single nucleotide polymorphisms, are a widely used type 1 diabetes risk-prediction tool. Type 1 diabetes screening studies have relied on a combination of biochemical (autoantibody) and GRS screening methodologies for identifying individuals at high-risk of type 1 diabetes. A limitation of these screening tools is that the presence of autoantibodies marks the initiation of β-cell loss, and is therefore not the best biomarker of progression to early-stage type 1 diabetes...
May 23, 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38795720/measuring-serum-testosterone-in-women
#19
JOURNAL ARTICLE
David J Handelsman, Susan R Davis
No abstract text is available yet for this article.
May 22, 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38782012/the-ongoing-quest-for-worldwide-iodine-sufficiency
#20
JOURNAL ARTICLE
Ray Cavanaugh
No abstract text is available yet for this article.
May 20, 2024: Lancet Diabetes & Endocrinology
journal
journal
47944
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.